Arrowhead Pharmaceuticals, Inc.

{
  "main_header": {
    "sid": 1150576,
    "name": "Arrowhead Pharmaceuticals, Inc.",
    "stock_name": "Arrowhead Pharmaceuticals, Inc.",
    "full_name": "Arrowhead Pharmaceuticals, Inc.",
    "name_url": "stocks-analysis/arrowhead-pharmaceuticals-inc",
    "exchange": 1,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "67.05",
    "chg": 50.48,
    "chgp": "304.65%",
    "dir": 1,
    "prev_price": "16.57",
    "mcapval": "9,180.73",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "US04280A1007",
    "curr_date": "Jan 23",
    "curr_time": "",
    "bse_nse_vol": "1.15 M",
    "exc_status": "Active",
    "traded_date": "Jan 23, 2026",
    "traded_date_str": "2026 01 23",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/arrowhead-pharmaceuticals-inc-1150576-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Arrowhead Pharmaceuticals Hits New 52-Week High of $46.89",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/arrowhead-pharmaceuticals-hits-new-52-week-high-of-4689-3731837",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ArrowheadPharma_priceRelatedfactors_3731837.png",
        "date": "2025-11-26 16:24:34",
        "description": "Arrowhead Pharmaceuticals, Inc. has achieved a new 52-week high, reflecting a significant performance increase over the past year. The company, with a market capitalization of USD 3,756 million, is noted for its innovative approaches in the biotech sector, despite facing financial challenges and a loss-making position."
      },
      {
        "title": "Arrowhead Pharmaceuticals Hits Day High with 9.42% Surge in Stock Price",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/arrowhead-pharmaceuticals-hits-day-high-with-942-surge-in-stock-price-3729434",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ArrowheadPharma_priceRelatedfactors_3729434.png",
        "date": "2025-11-25 16:39:04",
        "description": "Arrowhead Pharmaceuticals, Inc. saw a notable rise in stock performance on November 24, 2025, with significant gains over the past week and month. Despite strong year-to-date growth, the company faces challenges such as negative EBITDA and a high price-to-book ratio, reflecting a complex financial situation."
      },
      {
        "title": "Arrowhead Pharmaceuticals Hits New 52-Week High of $44.80",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/arrowhead-pharmaceuticals-hits-new-52-week-high-of-4480-3729408",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ArrowheadPharma_priceRelatedfactors_3729408.png",
        "date": "2025-11-25 16:17:39",
        "description": "Arrowhead Pharmaceuticals, Inc. has achieved a new 52-week high, reflecting its strong performance in the pharmaceuticals and biotechnology sector. The company has experienced significant growth over the past year, despite being in a loss-making position and not offering dividends, indicating a focus on reinvestment and expansion."
      },
      {
        "title": "Arrowhead Pharmaceuticals Hits New 52-Week High of $43.69",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/arrowhead-pharmaceuticals-hits-new-52-week-high-of-4369-3667254",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ArrowheadPharma_priceRelatedfactors_3667254.png",
        "date": "2025-11-03 17:01:37",
        "description": "Arrowhead Pharmaceuticals, Inc. achieved a new 52-week high of USD 43.69 on October 31, 2025, reflecting strong growth in the Pharmaceuticals & Biotechnology industry. Despite its loss-making status and challenges in profitability, the company has shown significant performance improvement over the past year, outpacing broader market gains."
      },
      {
        "title": "Arrowhead Pharmaceuticals Hits New 52-Week High at $43.33",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/arrowhead-pharmaceuticals-hits-new-52-week-high-at-4333-3661891",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ArrowheadPharma_priceRelatedfactors_3661891.png",
        "date": "2025-10-31 16:03:22",
        "description": "Arrowhead Pharmaceuticals, Inc. achieved a new 52-week high of USD 43.33 on October 30, 2025, reflecting strong performance in the pharmaceuticals sector. The company has seen a 72.62% growth over the past year, despite being loss-making, and has a market capitalization of USD 3,756 million."
      },
      {
        "title": "Arrowhead Pharmaceuticals Hits New 52-Week High of $40.74",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/arrowhead-pharmaceuticals-hits-new-52-week-high-of-4074-3659073",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ArrowheadPharma_priceRelatedfactors_3659073.png",
        "date": "2025-10-30 18:20:22",
        "description": "Arrowhead Pharmaceuticals has achieved a new 52-week high of USD 40.74, significantly up from its low of USD 9.57. The company, with a market cap of approximately USD 3,756 million, has seen a 64.38% stock increase over the past year, despite ongoing financial losses and a premium valuation."
      }
    ],
    "total": 24,
    "sid": "1150576",
    "stock_news_url": "https://www.marketsmojo.com/news/arrowhead-pharmaceuticals-inc-1150576"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Arrowhead Pharmaceuticals Hits New 52-Week High of $46.89

2025-11-26 16:24:34

Arrowhead Pharmaceuticals, Inc. has achieved a new 52-week high, reflecting a significant performance increase over the past year. The company, with a market capitalization of USD 3,756 million, is noted for its innovative approaches in the biotech sector, despite facing financial challenges and a loss-making position.

Read full news article

Arrowhead Pharmaceuticals Hits Day High with 9.42% Surge in Stock Price

2025-11-25 16:39:04

Arrowhead Pharmaceuticals, Inc. saw a notable rise in stock performance on November 24, 2025, with significant gains over the past week and month. Despite strong year-to-date growth, the company faces challenges such as negative EBITDA and a high price-to-book ratio, reflecting a complex financial situation.

Read full news article

Arrowhead Pharmaceuticals Hits New 52-Week High of $44.80

2025-11-25 16:17:39

Arrowhead Pharmaceuticals, Inc. has achieved a new 52-week high, reflecting its strong performance in the pharmaceuticals and biotechnology sector. The company has experienced significant growth over the past year, despite being in a loss-making position and not offering dividends, indicating a focus on reinvestment and expansion.

Read full news article

Arrowhead Pharmaceuticals Hits New 52-Week High of $43.69

2025-11-03 17:01:37

Arrowhead Pharmaceuticals, Inc. achieved a new 52-week high of USD 43.69 on October 31, 2025, reflecting strong growth in the Pharmaceuticals & Biotechnology industry. Despite its loss-making status and challenges in profitability, the company has shown significant performance improvement over the past year, outpacing broader market gains.

Read full news article

Arrowhead Pharmaceuticals Hits New 52-Week High at $43.33

2025-10-31 16:03:22

Arrowhead Pharmaceuticals, Inc. achieved a new 52-week high of USD 43.33 on October 30, 2025, reflecting strong performance in the pharmaceuticals sector. The company has seen a 72.62% growth over the past year, despite being loss-making, and has a market capitalization of USD 3,756 million.

Read full news article

Arrowhead Pharmaceuticals Hits New 52-Week High of $40.74

2025-10-30 18:20:22

Arrowhead Pharmaceuticals has achieved a new 52-week high of USD 40.74, significantly up from its low of USD 9.57. The company, with a market cap of approximately USD 3,756 million, has seen a 64.38% stock increase over the past year, despite ongoing financial losses and a premium valuation.

Read full news article

View All News